Načítá se...
Eculizumab therapy in gemcitabine-induced thrombotic microangiopathy in a renal transplant recipient
A renal transplant recipient 7 years post-transplantation, diagnosed with locally advanced pancreatic adenocarcinoma developed thrombotic microangiopathy (TMA) after treatment with gemcitabine and nab-paclitaxel. Gemcitabine was the most likely cause for TMA and was ceased. He received methylprednis...
Uloženo v:
| Vydáno v: | Oxf Med Case Reports |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6568204/ https://ncbi.nlm.nih.gov/pubmed/31214360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omz048 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|